| Ms Franziska Herpich, MD | |
|
4755 Ogletown Stanton Rd Ste 2e99, Newark, DE 19718-2200 | |
| (302) 733-5982 | |
| (302) 733-6081 |
| Full Name | Ms Franziska Herpich |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 10 Years |
| Location | 4755 Ogletown Stanton Rd Ste 2e99, Newark, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689051302 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christiana Care Health Services Inc | 9739097569 | 1248 |
News Archive
Using a novel analysis of the interactions among related genes, Duke University Medical Center researchers have uncovered some of the first evidence that complex genetic interactions account for autism risk. The Duke team found that the brain mechanism that normally stops or slows nerve impulses contributes to the disease.
Texas ranked dead last in the federal government's latest report card on the delivery of health services, falling short in areas ranging from acute hospital care to home treatment of the chronically ill. Texas scored 31.61 - less than half of top-ranked Minnesota's 67.31 - out of a possible 100 points in the Agency for Healthcare Research and Quality annual rankings.
Array BioPharma today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial. The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
› Verified 8 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770568107 PECOS PAC ID: 9739097569 Enrollment ID: O20031201000477 |
News Archive
Using a novel analysis of the interactions among related genes, Duke University Medical Center researchers have uncovered some of the first evidence that complex genetic interactions account for autism risk. The Duke team found that the brain mechanism that normally stops or slows nerve impulses contributes to the disease.
Texas ranked dead last in the federal government's latest report card on the delivery of health services, falling short in areas ranging from acute hospital care to home treatment of the chronically ill. Texas scored 31.61 - less than half of top-ranked Minnesota's 67.31 - out of a possible 100 points in the Agency for Healthcare Research and Quality annual rankings.
Array BioPharma today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial. The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
› Verified 8 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457593949 PECOS PAC ID: 9739097569 Enrollment ID: O20090715000610 |
News Archive
Using a novel analysis of the interactions among related genes, Duke University Medical Center researchers have uncovered some of the first evidence that complex genetic interactions account for autism risk. The Duke team found that the brain mechanism that normally stops or slows nerve impulses contributes to the disease.
Texas ranked dead last in the federal government's latest report card on the delivery of health services, falling short in areas ranging from acute hospital care to home treatment of the chronically ill. Texas scored 31.61 - less than half of top-ranked Minnesota's 67.31 - out of a possible 100 points in the Agency for Healthcare Research and Quality annual rankings.
Array BioPharma today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial. The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Franziska Herpich, MD 4755 Ogletown Stanton Rd Ste 2e99, Newark, DE 19718-2200 Ph: (302) 733-5982 | Ms Franziska Herpich, MD 4755 Ogletown Stanton Rd Ste 2e99, Newark, DE 19718-2200 Ph: (302) 733-5982 |
News Archive
Using a novel analysis of the interactions among related genes, Duke University Medical Center researchers have uncovered some of the first evidence that complex genetic interactions account for autism risk. The Duke team found that the brain mechanism that normally stops or slows nerve impulses contributes to the disease.
Texas ranked dead last in the federal government's latest report card on the delivery of health services, falling short in areas ranging from acute hospital care to home treatment of the chronically ill. Texas scored 31.61 - less than half of top-ranked Minnesota's 67.31 - out of a possible 100 points in the Agency for Healthcare Research and Quality annual rankings.
Array BioPharma today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial. The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
› Verified 8 days ago
Jonathan M Raser-schramm, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-733-1888 | |
Dr. Ayesha Silman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 Rockford Dr, Newark, DE 19713 Phone: 302-996-5480 | |
Yawar Abbas, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Rockford Center, 100 Rockford Dr, Newark, DE 19713 Phone: 302-996-5480 | |
Dr. Panna Kalyanji Jolapara, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18 Capano Drive, Apt C4, Newark, DE 19702 Phone: 302-292-8693 Fax: 302-292-8693 | |
Enrica Arnaudo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-266-9960 | |
Stephen Doyle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 | |
Lanny Edelsohn, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-266-9960 |